MENU
+Compare
MDNAF
Stock ticker: OTC
AS OF
Jul 3 closing price
Price
$0.65
Change
+$0.01 (+1.56%)
Capitalization
51.58M

MDNAF Medicenna Therapeutics Corp. Forecast, Technical & Fundamental Analysis

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company... Show more

MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MDNAF with price predictions
Jul 03, 2025

MDNAF sees its Stochastic Oscillator recovers from oversold territory

On June 26, 2025, the Stochastic Oscillator for MDNAF moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 66 instances where the indicator left the oversold zone. In of the 66 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MDNAF's RSI Oscillator exited the oversold zone, of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MDNAF just turned positive on July 02, 2025. Looking at past instances where MDNAF's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDNAF advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .

MDNAF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MDNAF as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

MDNAF moved below its 50-day moving average on May 28, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MDNAF crossed bearishly below the 50-day moving average on June 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDNAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MDNAF entered a downward trend on July 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.615) is normal, around the industry mean (16.648). P/E Ratio (0.000) is within average values for comparable stocks, (58.447). MDNAF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.259). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (268.529).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MDNAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDNAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MDNAF is expected to report earnings to fall 396.60% to -4 cents per share on August 08

Medicenna Therapeutics Corp. MDNAF Stock Earnings Reports
Q2'25
Est.
$-0.04
Q1'25
Beat
by $0.06
Q4'24
Est.
$-0.05
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.03
The last earnings report on June 26 showed earnings per share of 1 cents, beating the estimate of -4 cents. With 200.00 shares outstanding, the current market capitalization sits at 51.58M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2 Bloor Street W.
Phone
+1 416 648-5555
Employees
16
Web
https://www.medicenna.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGJTF80.267.05
+9.63%
Cargojet, Inc.
VHIBF8.070.03
+0.41%
VITALHUB CORP
KMERF35.55N/A
N/A
Komercni Banka A.S.
NGGTF14.23-0.47
-3.17%
National Grid PLC
SRSG0.07N/A
-5.32%
Spirits Time International, Inc.

MDNAF and Stocks

Correlation & Price change

A.I.dvisor tells us that MDNAF and DTIL have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDNAF and DTIL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDNAF
1D Price
Change %
MDNAF100%
-0.71%
DTIL - MDNAF
27%
Poorly correlated
+1.88%
HRTX - MDNAF
26%
Poorly correlated
+2.33%
ARWR - MDNAF
25%
Poorly correlated
-0.65%
CRBU - MDNAF
23%
Poorly correlated
N/A
MRVI - MDNAF
22%
Poorly correlated
+0.75%
More